Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Partially-Blind, Clinical Trial to Evaluate the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil, Compared to 10- and 13-Valent Pneumococcal Conjugate Vaccines

NCT05721456 is registered in ClinicalTrials.gov with Maria de Lourdes de Sousa Maia, MD as lead sponsor.

NCT NCT05721456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Partially-Blind, Clinical Trial to Evaluate the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil, Compared to 10- and 13-Valent Pneumococcal Conjugate Vaccines
Lead sponsor
Maria de Lourdes de Sousa Maia, MD
Phase
Phase 3
Overall status
Unknown status
Start date
August 28, 2023
Completion date
January 28, 2025
Enrollment
2,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal vaccines